The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
The global Hemostats market was valued at US$ 2745.5 million in 2023 and is anticipated to reach US$ 4120.4 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats.
Report Scope
The Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Hemostats Market Overview
1.1 Product Overview and Scope of Hemostats
1.2 Hemostats Segment by Type
1.2.1 Global Hemostats Market Value Comparison by Type (2024-2030)
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Hemostats Segment by Application
1.3.1 Global Hemostats Market Value by Application: (2024-2030)
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Global Hemostats Market Size Estimates and Forecasts
1.4.1 Global Hemostats Revenue 2019-2030
1.4.2 Global Hemostats Sales 2019-2030
1.4.3 Global Hemostats Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostats Market Competition by Manufacturers
2.1 Global Hemostats Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostats Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostats Average Price by Manufacturers (2019-2024)
2.4 Global Hemostats Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostats, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostats, Product Type & Application
2.7 Hemostats Market Competitive Situation and Trends
2.7.1 Hemostats Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostats Players Market Share by Revenue
2.7.3 Global Hemostats Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostats Retrospective Market Scenario by Region
3.1 Global Hemostats Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostats Global Hemostats Sales by Region: 2019-2030
3.2.1 Global Hemostats Sales by Region: 2019-2024
3.2.2 Global Hemostats Sales by Region: 2025-2030
3.3 Global Hemostats Global Hemostats Revenue by Region: 2019-2030
3.3.1 Global Hemostats Revenue by Region: 2019-2024
3.3.2 Global Hemostats Revenue by Region: 2025-2030
3.4 North America Hemostats Market Facts & Figures by Country
3.4.1 North America Hemostats Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostats Sales by Country (2019-2030)
3.4.3 North America Hemostats Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostats Market Facts & Figures by Country
3.5.1 Europe Hemostats Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostats Sales by Country (2019-2030)
3.5.3 Europe Hemostats Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostats Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostats Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostats Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostats Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostats Market Facts & Figures by Country
3.7.1 Latin America Hemostats Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostats Sales by Country (2019-2030)
3.7.3 Latin America Hemostats Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostats Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostats Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostats Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostats Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostats Sales by Type (2019-2030)
4.1.1 Global Hemostats Sales by Type (2019-2024)
4.1.2 Global Hemostats Sales by Type (2025-2030)
4.1.3 Global Hemostats Sales Market Share by Type (2019-2030)
4.2 Global Hemostats Revenue by Type (2019-2030)
4.2.1 Global Hemostats Revenue by Type (2019-2024)
4.2.2 Global Hemostats Revenue by Type (2025-2030)
4.2.3 Global Hemostats Revenue Market Share by Type (2019-2030)
4.3 Global Hemostats Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostats Sales by Application (2019-2030)
5.1.1 Global Hemostats Sales by Application (2019-2024)
5.1.2 Global Hemostats Sales by Application (2025-2030)
5.1.3 Global Hemostats Sales Market Share by Application (2019-2030)
5.2 Global Hemostats Revenue by Application (2019-2030)
5.2.1 Global Hemostats Revenue by Application (2019-2024)
5.2.2 Global Hemostats Revenue by Application (2025-2030)
5.2.3 Global Hemostats Revenue Market Share by Application (2019-2030)
5.3 Global Hemostats Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Corporation Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ethicon Hemostats Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Hemostats Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International Inc.
6.3.1 Baxter International Inc. Corporation Information
6.3.2 Baxter International Inc. Description and Business Overview
6.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Baxter International Inc. Hemostats Product Portfolio
6.3.5 Baxter International Inc. Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Corporation Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C. R. Bard Hemostats Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Corporation Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Medicines Company Hemostats Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anika Therapeutics Hemostats Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.6.1 Advanced Medical Solutions Corporation Information
6.6.2 Advanced Medical Solutions Description and Business Overview
6.6.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advanced Medical Solutions Hemostats Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences Corporation
6.8.1 Integra LifeSciences Corporation Corporation Information
6.8.2 Integra LifeSciences Corporation Description and Business Overview
6.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
6.8.5 Integra LifeSciences Corporation Recent Developments/Updates
6.9 B Braun Melsungen AG
6.9.1 B Braun Melsungen AG Corporation Information
6.9.2 B Braun Melsungen AG Description and Business Overview
6.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B Braun Melsungen AG Hemostats Product Portfolio
6.9.5 B Braun Melsungen AG Recent Developments/Updates
6.10 Gelita Medical GmbH
6.10.1 Gelita Medical GmbH Corporation Information
6.10.2 Gelita Medical GmbH Description and Business Overview
6.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gelita Medical GmbH Hemostats Product Portfolio
6.10.5 Gelita Medical GmbH Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Corporation Information
6.11.2 Equimedical Hemostats Description and Business Overview
6.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Equimedical Hemostats Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Corporation Information
6.12.2 Vascular Solutions Hemostats Description and Business Overview
6.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vascular Solutions Hemostats Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Corporation Information
6.13.2 Marine Polymer Technologies Hemostats Description and Business Overview
6.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Marine Polymer Technologies Hemostats Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
6.14 Z-Medica, LLC
6.14.1 Z-Medica, LLC Corporation Information
6.14.2 Z-Medica, LLC Hemostats Description and Business Overview
6.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Z-Medica, LLC Hemostats Product Portfolio
6.14.5 Z-Medica, LLC Recent Developments/Updates
6.15 CryoLife
6.15.1 CryoLife Corporation Information
6.15.2 CryoLife Hemostats Description and Business Overview
6.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CryoLife Hemostats Product Portfolio
6.15.5 CryoLife Recent Developments/Updates
6.16 BioCer Entwicklungs-GmbH.
6.16.1 BioCer Entwicklungs-GmbH. Corporation Information
6.16.2 BioCer Entwicklungs-GmbH. Hemostats Description and Business Overview
6.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
6.16.5 BioCer Entwicklungs-GmbH. Recent Developments/Updates
6.17 Biom'Up SAS
6.17.1 Biom'Up SAS Corporation Information
6.17.2 Biom'Up SAS Hemostats Description and Business Overview
6.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biom'Up SAS Hemostats Product Portfolio
6.17.5 Biom'Up SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostats Industry Chain Analysis
7.2 Hemostats Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostats Production Mode & Process
7.4 Hemostats Sales and Marketing
7.4.1 Hemostats Sales Channels
7.4.2 Hemostats Distributors
7.5 Hemostats Customers
8 Hemostats Market Dynamics
8.1 Hemostats Industry Trends
8.2 Hemostats Market Drivers
8.3 Hemostats Market Challenges
8.4 Hemostats Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
